Discovery & Development

How a new 3D bioprinter could – quite literally – add a new dimension to drug screening and disease modeling.

Epigenetic switches are being used to identify the optimal combination of transcription factors required to derive clinically valuable cell types.

A husband-and-wife-led team used mass spec to identify new drugs that “glue” proteins together. We spoke to Aneika Leney about the project.

When it comes to conducting clinical trials in emerging geographies, there are four key challenges to consider.

It was by serendipity that Hendrik Dietz learned how to make a virus trap. Now, his team may be sitting on a new way to combat disease.

Can a new malaria vaccine hold the key to reliable, durable protection?

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.

Using CRISPR to engineer cell therapies with multiple gene knockouts could be limited by double-strand breaks.

Could zinc finger therapy hold the key to treating Alzheimer’s disease?

Why are some COVID-19 vaccines linked to blood clots? Researchers have a theory...